国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
7期
817-819
,共3页
吴伟京%林景泰%彭和平%胡以则
吳偉京%林景泰%彭和平%鬍以則
오위경%림경태%팽화평%호이칙
肝门部胆管癌%诊断%治疗
肝門部膽管癌%診斷%治療
간문부담관암%진단%치료
Hilar cholangiocarcinoma%Diagnose%Treatment
目的 探讨肝门部胆管癌的临床特点与治疗方法.方法 回顾性分析55例肝门部胆管癌的临床资料,并行诊断与疗效分析.结果 55例患者中,根治性手术21例,局部切除6例,姑息性肝管空肠吻合术13例,胆道内支架引流术9例,经皮肝穿刺引流术6例.根治性切除患者生存期40d~5年9个月,平均25个月.姑息性胆管引流患者平均生存期为78d~19个月,平均8个月.结论 肝门部胆管癌的早期诊治、临床分期及手术的根治程度是影响患者生存率的主要因素.对于不能根治的患者,应设法引流,减轻黄疸,延长生存期.
目的 探討肝門部膽管癌的臨床特點與治療方法.方法 迴顧性分析55例肝門部膽管癌的臨床資料,併行診斷與療效分析.結果 55例患者中,根治性手術21例,跼部切除6例,姑息性肝管空腸吻閤術13例,膽道內支架引流術9例,經皮肝穿刺引流術6例.根治性切除患者生存期40d~5年9箇月,平均25箇月.姑息性膽管引流患者平均生存期為78d~19箇月,平均8箇月.結論 肝門部膽管癌的早期診治、臨床分期及手術的根治程度是影響患者生存率的主要因素.對于不能根治的患者,應設法引流,減輕黃疸,延長生存期.
목적 탐토간문부담관암적림상특점여치료방법.방법 회고성분석55례간문부담관암적림상자료,병행진단여료효분석.결과 55례환자중,근치성수술21례,국부절제6례,고식성간관공장문합술13례,담도내지가인류술9례,경피간천자인류술6례.근치성절제환자생존기40d~5년9개월,평균25개월.고식성담관인류환자평균생존기위78d~19개월,평균8개월.결론 간문부담관암적조기진치、림상분기급수술적근치정도시영향환자생존솔적주요인소.대우불능근치적환자,응설법인류,감경황달,연장생존기.
Objective To summarize the experience of diagnose and treatment for Hilar Cholangiocarinoma.Methods A retrospective clinical analysis was performed on the clinical data from 55cases of hilar cholangiocarinoma.Results 21 cases experienced surgical resection with 25 monthes of survival time.28 cases were performed simple drainage with 8 monthes of survival time.Conclusions Resection is the main metheod for the treatment of hilar cholangiocareinomas.The early diagnosis and radical resection are the main related factors influencing the therapeutic efficacy of hilar cholangiocarcinoma.The stents by endoscopy and by percutaneous placement can prolong survival.